Skip to main content

 9TMK | pdb_00009tmk

Structure of CYLD CAP-Gly2 bound to Listeria effector protein InlC


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 
    0.218 (Depositor), 0.220 (DCC) 
  • R-Value Work: 
    0.178 (Depositor), 0.183 (DCC) 
  • R-Value Observed: 
    0.180 (Depositor) 

Starting Models: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9TMK

This is version 1.1 of the entry. See complete history. 

Literature

Listeria promotes systemic infection by targeting the host deubiquitinase CYLD.

Ammendolia, D.A., Ellison, C.J., Zheng, Y., Coyaud, E., Laurent, E.M.N., Yan, B.R., Manning, B., Waldmann, A.K., Tan, J.M.J., Frendo-Cumbo, S., Lyons, C., Youn, J.Y., Raught, B., Ireton, K., Higgins, D.E., Elliott, P.R., Brumell, J.H.

(2026) Nat Commun 17

  • DOI: https://doi.org/10.1038/s41467-026-77063-5
  • Primary Citation Related Structures: 
    9TMK

  • PubMed Abstract: 

    Listeria monocytogenes (Lm) is an intracellular pathogen that can cause life-threatening systemic infections. Internalin C (InlC) is a secreted factor required for full Lm virulence in systemic models of infection by mechanisms that remain unclear. Here, we show that InlC binds to CYLD, a host deubiquitinase and regulator of innate immunity. Structurally, we reveal the LRR domain of InlC binds the CAP-Gly2 domain of CYLD, independently of InlC's binding site for other host target proteins. Lm strains harboring amino acid substitutions in InlC that selectively disrupt binding to CYLD were examined. We demonstrate that after Lm accesses the host cytosol, InlC recruits CYLD to ubiquitin-positive bacteria. Recruitment of CYLD was dependent on the host E3 ligase RNF213, a major initiator of ubiquitin-mediated defenses. Furthermore, InlC-CYLD binding contributed to Lm virulence in mice. Together, these findings reveal how a secreted bacterial factor promotes the recruitment of a host deubiquitinase to cytosolic bacteria in response to ubiquitin-mediated defenses.


  • Organizational Affiliation: 
    • Cell & Systems Biology Program, Hospital for Sick Children, Toronto, ON, Canada.

Macromolecule Content 

  • Total Structure Weight: 39.57 kDa 
  • Atom Count: 3,017 
  • Modeled Residue Count: 343 
  • Deposited Residue Count: 355 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Internalin C265Listeria monocytogenesMutation(s): 0 
Gene Names: inlC, irpA
UniProt
Find proteins for P71451 (Listeria monocytogenes serotype 1/2a (strain EGD / Mackaness))
Explore P71451 
Go to UniProtKB:  P71451
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP71451
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Ubiquitin carboxyl-terminal hydrolase CYLD90Homo sapiensMutation(s): 0 
Gene Names: CYLD, CYLD1, KIAA0849, HSPC057
EC: 3.4.19.12
UniProt & NIH Common Fund Data Resources
Find proteins for Q9NQC7 (Homo sapiens)
Explore Q9NQC7 
Go to UniProtKB:  Q9NQC7
PHAROS:  Q9NQC7
GTEx:  ENSG00000083799 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9NQC7
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free:  0.218 (Depositor), 0.220 (DCC) 
  • R-Value Work:  0.178 (Depositor), 0.183 (DCC) 
  • R-Value Observed: 0.180 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 58.833α = 90
b = 70.01β = 90
c = 97.723γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
DIALSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Cancer Research UKUnited KingdomDRCPFA-Jun24/100003
UK Research and Innovation (UKRI)United KingdomMR/Z506217/1

Revision History  (Full details and data files)

  • Version 1.0: 2026-09-30
    Type: Initial release
  • Version 1.1: 2026-10-14
    Changes: Database references